213 related articles for article (PubMed ID: 19689266)
21. Hydrogen peroxide content and pH of expired breath condensate from patients with asthma and COPD.
Murata K; Fujimoto K; Kitaguchi Y; Horiuchi T; Kubo K; Honda T
COPD; 2014 Feb; 11(1):81-7. PubMed ID: 24111595
[TBL] [Abstract][Full Text] [Related]
22. Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap.
Takayama Y; Ohnishi H; Ogasawara F; Oyama K; Kubota T; Yokoyama A
Int J Chron Obstruct Pulmon Dis; 2018; 13():2525-2532. PubMed ID: 30174422
[TBL] [Abstract][Full Text] [Related]
23. [Value of Fractional Exhaled Nitric Oxide after Using a Beta-2 Bronchodilator in the Differential Diagnosis of Bronchial Asthma and Chronic Obstructive Pulmonary Disease].
Ura M; Tanaka H; Takahashi K; Yamazaki H; Fujimoto K
Rinsho Byori; 2016 Feb; 64(2):127-32. PubMed ID: 27311275
[TBL] [Abstract][Full Text] [Related]
24. Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease.
Rutgers SR; van der Mark TW; Coers W; Moshage H; Timens W; Kauffman HF; Koëter GH; Postma DS
Thorax; 1999 Jul; 54(7):576-80. PubMed ID: 10377200
[TBL] [Abstract][Full Text] [Related]
25. Clinical use of exhaled biomarkers in COPD.
O'Reilly P; Bailey W
Int J Chron Obstruct Pulmon Dis; 2007; 2(4):403-8. PubMed ID: 18268915
[TBL] [Abstract][Full Text] [Related]
26. Exhaled nitric oxide: A biomarker for chronic obstructive pulmonary disease.
Kobayashi S; Hanagama M; Ishida M; Ono M; Sato H; Yanai M
Respir Investig; 2021 May; 59(3):364-366. PubMed ID: 33602651
[TBL] [Abstract][Full Text] [Related]
27. Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity.
Feng JX; Lin Y; Lin J; He SS; Chen MF; Wu XM; Xu YZ
J Korean Med Sci; 2017 Mar; 32(3):439-447. PubMed ID: 28145647
[TBL] [Abstract][Full Text] [Related]
28. Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects.
Malerba M; Ragnoli B; Corradi M
Monaldi Arch Chest Dis; 2008 Sep; 69(3):128-33. PubMed ID: 19065847
[TBL] [Abstract][Full Text] [Related]
29. Exhaled NO and breath condensate.
Baraldi E; Carraro S
Paediatr Respir Rev; 2006; 7 Suppl 1():S20-2. PubMed ID: 16798565
[TBL] [Abstract][Full Text] [Related]
30. Exhaled nitric oxide correlated with induced sputum findings in COPD.
Silkoff PE; Martin D; Pak J; Westcott JY; Martin RJ
Chest; 2001 Apr; 119(4):1049-55. PubMed ID: 11296168
[TBL] [Abstract][Full Text] [Related]
31. The clinical utility of biomarkers in asthma and COPD.
Snell N; Newbold P
Curr Opin Pharmacol; 2008 Jun; 8(3):222-35. PubMed ID: 18468485
[TBL] [Abstract][Full Text] [Related]
32. Exhaled breath condensate analysis in patients with COPD.
Montuschi P
Clin Chim Acta; 2005 Jun; 356(1-2):22-34. PubMed ID: 15936301
[TBL] [Abstract][Full Text] [Related]
33. Exhaled nitric oxide measure using multiple flows in clinically relevant subgroups of COPD.
Bazeghi N; Gerds TA; Budtz-Jørgensen E; Hove J; Vestbo J
Respir Med; 2011 Sep; 105(9):1338-44. PubMed ID: 21530214
[TBL] [Abstract][Full Text] [Related]
34. Monitoring oxidative stress during chronic obstructive pulmonary disease exacerbations using malondialdehyde.
Antus B; Harnasi G; Drozdovszky O; Barta I
Respirology; 2014 Jan; 19(1):74-9. PubMed ID: 23834671
[TBL] [Abstract][Full Text] [Related]
35. Repeatability of exhaled nitric oxide measurements in patients with COPD.
Rouhos A; Kainu A; Piirilä P; Sarna S; Lindqvist A; Karjalainen J; Sovijärvi AR
Clin Physiol Funct Imaging; 2011 Jan; 31(1):26-31. PubMed ID: 21143751
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of a pattern of exhaled breath condensate biomarkers in asthmatic children.
Maloča Vuljanko I; Turkalj M; Nogalo B; Bulat Lokas S; Plavec D
Allergol Immunopathol (Madr); 2017; 45(1):2-10. PubMed ID: 27592280
[TBL] [Abstract][Full Text] [Related]
37. Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation.
Corradi M; Pignatti P; Manini P; Andreoli R; Goldoni M; Poppa M; Moscato G; Balbi B; Mutti A
Eur Respir J; 2004 Dec; 24(6):1011-7. PubMed ID: 15572547
[TBL] [Abstract][Full Text] [Related]
38. Exhaled Hydrogen Sulfide Predicts Airway Inflammation Phenotype in COPD.
Zhang J; Wang X; Chen Y; Yao W
Respir Care; 2015 Feb; 60(2):251-8. PubMed ID: 25336529
[TBL] [Abstract][Full Text] [Related]
39. Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases.
Carpagnano GE; Lacedonia D; Carone M; Soccio P; Cotugno G; Palmiotti GA; Scioscia G; Foschino Barbaro MP
J Breath Res; 2016 Apr; 10(2):026005. PubMed ID: 27063576
[TBL] [Abstract][Full Text] [Related]
40. Exhaled nitric oxide monitoring in COPD using a portable analyzer.
de Laurentiis G; Maniscalco M; Cianciulli F; Stanziola A; Marsico S; Lundberg JO; Weitzberg E; Sofia M
Pulm Pharmacol Ther; 2008 Aug; 21(4):689-93. PubMed ID: 18547853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
